Search research articles
Contact Us
Filters
Showing results (51-60 of 325) with videos related to
Page
of 33
Sort By:
Alimentary Pharmacology & Therapeutics
|
November 6, 2021
Editorial: biomarkers for alcohol-related liver fibrosis-almost there? Authors' reply
Stine Johansen, Aleksander Krag, Morten Karsdal, et al.
Journal of Hepatology
|
July 6, 2025
Reframing the spectrum of steatotic liver disease as a dynamic concept
Zobair M Younossi, Shira Zelber-Sagi, Aleksander Krag
Zeitschrift Fur Gastroenterologie
|
January 18, 2022
Diagnostic challenges in patients with alcohol-related liver disease
Aleksander Krag, Tania Roskams, Massimo Pinzani, et al.
Alimentary Pharmacology & Therapeutics
|
August 23, 2025
Editorial: Implementing Risk Assessment Tools for MetALD in Clinical Practice-Authors' Reply
Nikolaj Torp, Mads Israelsen, Stine Johansen, et al.
Gut
|
March 9, 2010
Hyponatraemia during terlipressin therapy
Aleksander Krag, Lise Hobolth, Søren Møller, et al.
Advances in Therapy
|
November 20, 2008
Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome
Aleksander Krag, Tine Borup, Søren Møller, et al.
Clinical Physiology and Functional Imaging
|
October 14, 2015
Contemporary use of elastography in liver fibrosis and portal hypertension
Maja Thiele, Maria Kjaergaard, Peter Thielsen, et al.
Journal of Gastroenterology and Hepatology
|
August 28, 2014
Acute kidney injury and hepatorenal syndrome in cirrhosis
Mads Egerod Israelsen, Lise Lotte Gluud, Aleksander Krag
Gastroenterology
|
March 25, 2022
The Negative Bidirectional Interaction Between Climate Change and the Prevalence and Care of Liver Disease: A Joint BSG, BASL, EASL, and AASLD Commentary
Mhairi C Donnelly, William Stableforth, Aleksander Krag, et al.
Journal of Hepatology
|
January 19, 2026
Is liver steatosis a disease or the emperor's new clothes?
Aleksander Krag, Frank Tacke, Mads Israelsen, et al.
Page
of 33
Search research articles
Search
Showing results (51-60 of 325) with videos related to
Sort By:
Page
of 33
Alimentary Pharmacology & Therapeutics
|
November 6, 2021
Editorial: biomarkers for alcohol-related liver fibrosis-almost there? Authors' reply
Stine Johansen, Aleksander Krag, Morten Karsdal, et al.
Journal of Hepatology
|
July 6, 2025
Reframing the spectrum of steatotic liver disease as a dynamic concept
Zobair M Younossi, Shira Zelber-Sagi, Aleksander Krag
Zeitschrift Fur Gastroenterologie
|
January 18, 2022
Diagnostic challenges in patients with alcohol-related liver disease
Aleksander Krag, Tania Roskams, Massimo Pinzani, et al.
Alimentary Pharmacology & Therapeutics
|
August 23, 2025
Editorial: Implementing Risk Assessment Tools for MetALD in Clinical Practice-Authors' Reply
Nikolaj Torp, Mads Israelsen, Stine Johansen, et al.
Gut
|
March 9, 2010
Hyponatraemia during terlipressin therapy
Aleksander Krag, Lise Hobolth, Søren Møller, et al.
Advances in Therapy
|
November 20, 2008
Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome
Aleksander Krag, Tine Borup, Søren Møller, et al.
Clinical Physiology and Functional Imaging
|
October 14, 2015
Contemporary use of elastography in liver fibrosis and portal hypertension
Maja Thiele, Maria Kjaergaard, Peter Thielsen, et al.
Journal of Gastroenterology and Hepatology
|
August 28, 2014
Acute kidney injury and hepatorenal syndrome in cirrhosis
Mads Egerod Israelsen, Lise Lotte Gluud, Aleksander Krag
Gastroenterology
|
March 25, 2022
The Negative Bidirectional Interaction Between Climate Change and the Prevalence and Care of Liver Disease: A Joint BSG, BASL, EASL, and AASLD Commentary
Mhairi C Donnelly, William Stableforth, Aleksander Krag, et al.
Journal of Hepatology
|
January 19, 2026
Is liver steatosis a disease or the emperor's new clothes?
Aleksander Krag, Frank Tacke, Mads Israelsen, et al.
Page
of 33